Precision Medicine News and Updates | Precision Medicine Online
BMS third quarter revenues increased 8 percent to $11.90 billion, with its growth portfolio now making up half of total revenues. Amgen Sees Strong Growth for Precision Oncology Drugs in Q3. Sales for Lumakras and Blincyto in particular soared during the third quarter as the firm's overall revenues climbed 23 percent year over year.
Precision Oncology News - Precision Medicine Online
Nov 5, 2024 · NCCN Adds Prostate Cancer to Genetic Risk Assessment Guidelines. Nov 7, 2024. Gilead Sciences Focuses on New Multiple Myeloma CAR T Amid Flat Q3 Cell Therapy Sales. Nov 6, 2024.
Breaking News - Precision Medicine Online
Nov 4, 2024 · Viracta Therapeutics Cutting 42 Percent of Workforce, Reducing Board Seats in Restructuring. The restructuring is aimed at freeing up resources so the firm can advance its EBV-positive peripheral T-cell lymphoma drug toward the market. Nov 07, 2024.
Breaking News - Precision Medicine Online
Oct 18, 2024 · The LRRK2 Investigative Therapeutics Exchange aims to advance basic sciences and support development of new drugs and LRRK2-specific biomarkers.
Precision Oncology in 2022: New Drugs and Tests Amid Ongoing …
Jan 4, 2023 · NEW YORK – Looking back at 2022, plenty of new CAR T-cell, radioligand, and biomarker-defined treatments entered the market, as did new tissue and liquid biopsy tests to identify cancer patients eligible for these therapies.
Genetic Testing Challenges in Precision Medicine: Li-Fraumeni …
1 day ago · Precision Medicine Online and My Gene Counsel have partnered since 2019 on the "Genetic Testing Challenges" series to highlight real-world issues medical professionals are encountering as genetic tests are increasingly used in patient care.
Genomics Technology, Tools & Methods - Precision Medicine Online
Oct 29, 2024 · Sep 11, 2024. New Data Shore Up Evidence for Paired Tumor Origin, Molecular Testing in Cancer of Unknown Primary. Load More. The latest news on life science tools and technology in genetics, genomics, and molecular diagnostics from Precision Medicine Online.
Trace Neuroscience Launches With $101M Series A Funding
13 hours ago · NEW YORK – Trace Neuroscience launched on Tuesday, having raised $101 million in a Series A financing round and with a lead therapeutic development program exploring an RNA-based treatment approach for certain patients with amyotrophic lateral sclerosis (ALS). The Series A funding round was led by Third Rock Ventures, and included investors ...
Molecular Diagnostics News | Precision Medicine Online
Oct 15, 2024 · Foresight Diagnostics Founders Respond to Roche Lawsuit, Says Claims Asserted in Bad Faith. Oct 3, 2024. Researchers Stress Specificity of Grail Multi-Cancer Detection Test in Response to Study Criticism. Oct 2, 2024.
Genomics Research & Discovery | Precision Medicine Online
Oct 7, 2024 · Starting next year, the network will implement a population genomic screening pilot program for common, actionable genomic conditions in a primary care setting over five years. Researchers will evaluate the clinical effectiveness and economic impact of this approach through a small study at a single ...